Last updated on September 2020

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201) a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered Non-infectious Virus (AAV) as a "Shuttle".

Find a site near you

Start Over

Arkansas Children's Hospital

Little Rock, AR United States
  Connect »

Loma Linda Children's Hospital

San Bernardino, CA United States
  Connect »

C.S. Mott Children's Hospital

Ann Arbor, MI United States
  Connect »

St Thomas' Hospital

London, United Kingdom
  Connect »

Manchester Royal Infirmary

Manchester, United Kingdom
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.